Title : Feasibility study of biweekly CPT-11 plus CDDP for S-1- and paclitaxel-refractory, metastatic gastric cancer.

Pub. Date : 2006 Mar-Apr

PMID : 16619577






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Feasibility study of biweekly CPT-11 plus CDDP for S-1- and paclitaxel-refractory, metastatic gastric cancer. Irinotecan proteasome 26S subunit, non-ATPase 1 Homo sapiens
2 CONCLUSION: Biweekly CPT-11 plus CDDP was feasible for S-1- and paclitaxel-refractory metastatic gastric cancer, with moderate activity and favorable toxicity. Irinotecan proteasome 26S subunit, non-ATPase 1 Homo sapiens